Example: Heart Attack

Clinical Trials Sponsored by Xenon Pharmaceuticals Inc

Total 10 results

NCT03796962

Recruiting

A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy

Conditions: Focal Epilepsy
NCT03468725

Completed

Safety, Tolerability, Pharmacokinetics and Effects on Transcranial Magnetic Stimulation of Oral Doses of XEN1101

Conditions: Healthy Male Volunteers
NCT03467100

Completed

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901

Conditions: Healthy Volunteers
NCT03340220

Active, not recruiting

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN1101

Conditions: Healthy Volunteers
NCT02656043

Completed

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Conditions: Acne Vulgaris
NCT01486446

Completed

Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia

Conditions: Primary Erythromelalgia; Inherited Erythromelalgia
NCT01195636

Completed

A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)

Conditions: Postherpetic Neuralgia
NCT01090622

Completed

Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)

Conditions: Primary Erythromelalgia; Inherited Erythromelalgia
NCT00954356

Completed

Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction

Conditions: Dental Pain
NCT00813670

Completed

Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers

Conditions: Healthy Human Volunteers